Health Care Rx
Download Health Care Rx full books in PDF, epub, and Kindle. Read online free Health Care Rx ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Clayton M. Christensen |
| Publisher | : McGraw Hill Professional |
| Total Pages | : 496 |
| Release | : 2008-10-31 |
| Genre | : Business & Economics |
| ISBN | : 0071592091 |
A groundbreaking prescription for health care reform--from a legendaryleader in innovation . . . Our health care system is in critical condition. Each year, fewer Americans can afford it, fewer businesses can provide it, and fewer government programs can promise it for future generations. We need a cure, and we need it now. Harvard Business School’s Clayton M. Christensen—whose bestselling The Innovator’s Dilemma revolutionized the business world—presents The Innovator’s Prescription, a comprehensive analysis of the strategies that will improvehealth care and make it affordable. Christensen applies the principles of disruptive innovation to the broken health care system with two pioneers in the field—Dr. Jerome Grossman and Dr. Jason Hwang. Together, they examine arange of symptoms and offer proven solutions. YOU’LL DISCOVER HOW “Precision medicine” reduces costs and makes good on the promise of personalized care Disruptive business models improve quality, accessibility, and affordability by changing the way hospitals and doctors work Patient networks enable better treatment of chronic diseases Employers can change the roles they play in health care to compete effectively in the era of globalization Insurance and regulatory reforms stimulate disruption in health care
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 235 |
| Release | : 2018-03-01 |
| Genre | : Medical |
| ISBN | : 0309468086 |
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
| Author | : |
| Publisher | : |
| Total Pages | : 44 |
| Release | : 1988 |
| Genre | : Health insurance |
| ISBN | : |
| Author | : Sheila Shulman |
| Publisher | : CRC Press |
| Total Pages | : 216 |
| Release | : 1998-06-18 |
| Genre | : Medical |
| ISBN | : 9780789005120 |
PBMs: Reshaping the Pharmaceutical Distribution Network provides HMOs and other third-party payers with information on the new and increasingly important role of pharmaceutical benefit companies (PBMs) in the health care industry. From this text, you will learn how PBMs can maintain and deliver a quality, cost-effective drug benefit plan to your company while achieving the anticipated market share for the product. PBMs: Reshaping the Pharmaceutical Distribution Network offers you suggestions on how to choose which PBM service is correct for your business, such as what qualifications to look for in a PBM, as well as what questions you should ask a respective company. This text also offers ways on how your company can benefit from becoming a client and may make your business more competitive in the pharmaceutical industry. PBMs: Reshaping the Pharmaceutical Distribution Network also informs you about the controversies that have arisen concerning the new position of PBMs in the industry. Through research and evaluation, this text addresses these issues from many different perspectives and gives you insight into other topics concerning PBMs, including: operating methods that PBMs currently rely on for designing and overseeing a drug benefit plan how the Food and Drug Administration currently views the role of PBMs and why they are contemplating regulatory intervention alerting PBMs, pharmacies, pharmaceutical companies, and managed care organizations to new legal issues involving fraud and abuse affecting pharmacy benefit management and pharmaceutical manufacturers reasons why retail drug chains and pharmacist organizations oppose recent industry developments regarding PBMs whether or not PBMs reflect a move toward greater centralized decisionmaking in the health care systemIn addition, PBMs: Reshaping the Pharmaceutical Distribution Network offers pharmaceutical companies, health care providers, and managed care organizations several suggestions for further research, which may make your business or your business relationships more efficient and productive in the future. If you or your company are considering the services of a pharmacy benefit management, PBMs: Reshaping the Pharmaceutical Distribution Network will guide you in choosing a company that helps you deliver the most cost-effective and efficient pharmaceutical benefits to customers.
| Author | : Nora Roberts |
| Publisher | : St. Martin's Press |
| Total Pages | : 475 |
| Release | : 2022-05-24 |
| Genre | : Fiction |
| ISBN | : 1250278201 |
#1 New York Times bestselling author Nora Roberts introduces an unforgettable thief in an unputdownable new novel... Greed. Desire. Obsession. Revenge . . . It’s all in a night’s work. Harry Booth started stealing at nine to keep a roof over his ailing mother’s head, slipping into luxurious, empty homes at night to find items he could trade for precious cash. When his mother finally succumbed to cancer, he left Chicago—but kept up his nightwork, developing into a master thief with a code of honor and an expertise in not attracting attention—or getting attached. Until he meets Miranda Emerson, and the powerful bond between them upends all his rules. But along the way, Booth has made some dangerous associations, including the ruthless Carter LaPorte, who sees Booth as a tool he controls for his own profit. Knowing LaPorte will leverage any personal connection, Booth abandons Miranda for her own safety—cruelly, with no explanation—and disappears. But the bond between Miranda and Booth is too strong, pulling them inexorably back together. Now Booth must face LaPorte, to truly free himself and Miranda once and for all.
| Author | : Navarro |
| Publisher | : Jones & Bartlett Publishers |
| Total Pages | : 659 |
| Release | : 2008-12-11 |
| Genre | : Medical |
| ISBN | : 076378883X |
Managed Care Pharmacy Practice, Second Edition offers information critical to the development and operation of a managed care pharmacy program. The text also covers the changes that have taken place within the delivery of pharmacy services, as well as the evolving role of pharmacists.
| Author | : |
| Publisher | : U.S. Government Printing Office |
| Total Pages | : 94 |
| Release | : 1998 |
| Genre | : Business & Economics |
| ISBN | : |
| Author | : United States. Department of Veterans Affairs |
| Publisher | : |
| Total Pages | : 22 |
| Release | : 2004 |
| Genre | : Families of military personnel |
| ISBN | : |
| Author | : Mitchell J. Stoklosa |
| Publisher | : |
| Total Pages | : 428 |
| Release | : 1986 |
| Genre | : Medical |
| ISBN | : 9780812110074 |
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 483 |
| Release | : 2017-09-28 |
| Genre | : Medical |
| ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
